ZOTANSEZota Health Care LImitedMediumNeutral
Announced Fri, 22 May · 18:37 IST

Zota Health Care Limited has informed the Exchange about Acquisition of 39,794 equity shares of M/s Davaindia Health Mart Limited, Wholly Owned Subsidiary of the Company, by way of subscription to the right issue.

Listed Co AcquisitionStrategic Transactions View source PDF

ZOTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.7%1-day move
₹1190.00
prior close
₹1190.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.3+1.8+0.9-1.9-1.7-5.6-5.9-5.5-4.5-0.3+2.2+16.7+8.2
Up moveDown movePending
AI summary

Zota Health Care's Board approved subscribing to a rights issue of its wholly owned subsidiary Davaindia Health Mart Limited, acquiring 39,794 equity shares at Rs. 4,300 per share (including Rs. 4,290 premium), totaling approximately Rs. 16,999.96 lakhs (~Rs. 170 crore). Davaindia operates a retail generic pharmacy chain under a Company Owned Company Operated (COCO) model and reported turnover of Rs. 267.71 crore for FY 2025-26. This comes alongside other subsidiary investments during the year, including additional subscriptions in Davaindia (Rs. 2,529.56 lakhs for 58,827 shares) and investments in KMHP Ventures, Curexis Ventures, and Everyday Beauty Care Limited.

Likely market impact

The acquisition reinforces Zota Health Care's ownership of its retail generic pharmacy subsidiary, committing significant capital (~Rs. 170 crore) to a subsidiary with nearly Rs. 268 crore in annual turnover. This signals continued focus on expanding the pharmacy retail vertical, though large capital outflows into loss-making subsidiaries warrant monitoring.